Generic medicines

Generics manufacturers call for drugs manufacturing to move back to Europe from India and China

Generics manufacturers have called for European leaders to move drugs manufacturing out of India and China to provide stability to help stabilise the medicines supply chain.…

Labour Party’s compulsory licensing plans would ‘undermine’ medicines development, says pharmaceutical industry

Compulsory licensing to secure generic versions of patented medicines would “completely undermine” medicines development, the Association of the British Pharmaceutical Industry has said in its response to plans announced by Jeremy Corbyn, leader of the Labour Party.…

Government reforms of Category M reimbursement risk ‘exacerbating’ drug shortages, says PSNC

The government risks making drugs shortages worse with its generics reimbursement reforms, unless the proposals are rolled out gradually, the Pharmaceutical Services Negotiating Committee has said.…

Delayed market entry for generic buprenorphine patches could have cost NHS £500,000, study concludes

Patent protection strategies that delayed the entry of multiple generic buprenorphine patches into the market in 2016 potentially resulted in £500,000 worth of savings being lost to the NHS.…

DHSC to reform Category M reimbursement prices by April 2020

The government has proposed adjusting Category M drug reimbursement prices to ensure that pharmacy contractors are receiving equitable access to the medicines margin.…

NHS pays twice the price for generic medicines that manufacturers charge, finds report

The NHS is paying double the initial cost to wholesalers for Category M generic drugs, according to a report commissioned by the British Generic Manufacturers Association, the trade body representing generics manufacturers.…

Generics manufacturer Bristol Laboratories regains full good manufacturing practice status

Generics manufacturer Bristol Laboratories’ good manufacturing practice status has been fully restored, the company has announced. …

Government delays consultation with pharmaceutical industry over generics price limiting powers

A government consultation with the pharmaceutical industry over plans to use new powers to limit the price of generic medicines has been delayed until later in 2019, the Department of Health and Social Care has said.…

Drug rehabilitation charities spent millions on generics price concessions in 2018

Non-NHS organisations, including charities and local authorities, have had to pay £5.6m for drugs under the generics price concessions scheme in 2018, data analysts have found.…

Generics manufacturers have spent €700m on FMD implementation, says BGMA

Generics manufacturers across the EU have spent €700m on implementing the Falsified Medicines Directive, the British Generics Manufacturers Association has estimated.…